148 related articles for article (PubMed ID: 20131183)
1. Complimentary roles for N-terminal pro-B-type natriuretic peptide and spirometry to assess functional capacity in patients with complex mixed heart valve disease.
Bissessor N; Wee YS; Jayasinghe R; Zeng I; Lowe B; Kolbe J; Ellyet K; Kerr A; White H; Stewart R
Kardiol Pol; 2010 Jan; 68(1):1-10. PubMed ID: 20131183
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of NT-proBNP in the assessment of patients with aortic or mitral regurgitation.
Petracca F; Affuso F; Di Conza P; Micillo F; Castellano G; Guardasole V; Scopacasa F; Saccà L; Fazio S
J Cardiovasc Med (Hagerstown); 2009 Dec; 10(12):928-32. PubMed ID: 19606057
[TBL] [Abstract][Full Text] [Related]
3. Natriuretic peptides for the prediction of severely impaired peak VO2 in patients with lung disease.
Maeder MT; Brutsche MH; Christ A; Reichlin T; Staub D; Noveanu M; Breidthardt T; Potocki M; Mueller C
Respir Med; 2009 Sep; 103(9):1337-45. PubMed ID: 19375295
[TBL] [Abstract][Full Text] [Related]
4. Aminoterminal B-type pro-natriuretic peptide as a marker of recovery after high-risk coronary artery bypass grafting in patients with ischemic heart disease and severe impaired left ventricular function.
Rothenburger M; Stypmann J; Bruch C; Wichter T; Hoppe M; Drees G; Berendes E; Huelsken G; Loeher A; Welp H; Röttger C; Schmid C; Scheld HH; Tjan TD
J Heart Lung Transplant; 2006 May; 25(5):596-602. PubMed ID: 16678040
[TBL] [Abstract][Full Text] [Related]
5. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
[TBL] [Abstract][Full Text] [Related]
6. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
Toblli JE; Lombraña A; Duarte P; Di Gennaro F
J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
[TBL] [Abstract][Full Text] [Related]
7. Plasma N-terminal protype-B natriuretic peptide levels in risk assessment of patients with mitral regurgitation secondary to ischemic and nonischemic dilated cardiomyopathy.
Dini FL; Fontanive P; Conti U; Andreini D; Cabani E; De Tommasi SM
Am Heart J; 2008 Jun; 155(6):1121-7. PubMed ID: 18513528
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of N-terminal pro-B-type natriuretic peptide for conservatively and surgically treated patients with aortic valve stenosis.
Weber M; Hausen M; Arnold R; Nef H; Moellman H; Berkowitsch A; Elsaesser A; Brandt R; Mitrovic V; Hamm C
Heart; 2006 Nov; 92(11):1639-44. PubMed ID: 16740919
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of NT-proBNP in assessment of right ventricular function in children after tetralogy of Fallot correction - a preliminary study.
Pietrzak R; Werner B
Kardiol Pol; 2009 Apr; 67(4):378-83. PubMed ID: 19492250
[TBL] [Abstract][Full Text] [Related]
10. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
[TBL] [Abstract][Full Text] [Related]
11. Left ventricular remodelling in patients with moderate systolic dysfunction after myocardial infarction: favourable effects of exercise training and predictive role of N-terminal pro-brain natriuretic peptide.
Giallauria F; Cirillo P; Lucci R; Pacileo M; De Lorenzo A; D'Agostino M; Moschella S; Psaroudaki M; Del Forno D; Orio F; Vitale DF; Chiariello M; Vigorito C
Eur J Cardiovasc Prev Rehabil; 2008 Feb; 15(1):113-8. PubMed ID: 18277196
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation.
Shelton RJ; Clark AL; Goode K; Rigby AS; Cleland JG
Eur Heart J; 2006 Oct; 27(19):2353-61. PubMed ID: 16952921
[TBL] [Abstract][Full Text] [Related]
13. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
David S; Kümpers P; Seidler V; Biertz F; Haller H; Fliser D
Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
[TBL] [Abstract][Full Text] [Related]
16. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
17. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.
Potocki M; Mair J; Weber M; Hamm C; Burkard T; Hiemetzberger R; Peters K; Jander N; Cron TA; Hess N; Hoffmann A; Gekeler H; Gohlke-Bärwolf C; Buser P; Mueller C
Am J Cardiol; 2009 Aug; 104(4):559-64. PubMed ID: 19660612
[TBL] [Abstract][Full Text] [Related]
18. Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease.
Weber M; Arnold R; Rau M; Elsaesser A; Brandt R; Mitrovic V; Hamm C
Eur Heart J; 2005 May; 26(10):1023-30. PubMed ID: 15781428
[TBL] [Abstract][Full Text] [Related]
19. N-terminal pro-brain natriuretic peptide, kidney disease and outcome in patients with chronic heart failure.
Bruch C; Reinecke H; Stypmann J; Rothenburger M; Schmid C; Breithardt G; Wichter T; Gradaus R
J Heart Lung Transplant; 2006 Sep; 25(9):1135-41. PubMed ID: 16962477
[TBL] [Abstract][Full Text] [Related]
20. Natriuretic peptides and myocardial oxygen supply-to-demand ratio in patients with aortic stenosis.
Wagner JA; Störk S; Weidemann F; Strotmann J; Fiedel C; Ertl G; Voelker W
Eur J Clin Invest; 2007 Jun; 37(6):463-71. PubMed ID: 17537153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]